Tag Archives: immunology

Another excellent & informative interview with whistle blower Dr Judy Mikovits – listen & learn how to protect your health

An interview here with Dr Judy Mikovits, from certified nutrition specialist Anne Louise at annlouise.com

“Shaking up the old boys’ club, molecular biologist, biochemist, and co-author of the best-selling book, Plague of Corruption, Dr. Judy Mikovits is making headlines across the world with groundbreaking revelations of what she considers the sinister truth behind the current pandemic. In what may be the most mind-blowing interview I’ve done to date, Dr. Mikovits answers many of the most pressing questions my audience is asking, including: Is this a naturally occurring or a lab-grown virus? Are the numbers being inflated? If you were hospitalized with this virus, what should you do? Are we headed for mandatory vaccination? What are the most effective ways to both prevent and treat this virus? This is an interview you can’t afford to miss.

https://annlouise.com/2020/05/04/plague-of-corruption-episode-16-dr-judy-a-mikovits/?fbclid=IwAR0zy9dju3OBIJ4pJAwRX5DHskUqxJEhlAzw8624fXafwgjbk6usmPFLFx4

A coincidence is it that 3 years ago: “A laboratory in Wuhan is on the cusp of being cleared to work with the world’s most dangerous pathogens”?

“Inside the Chinese lab poised to study world’s most dangerous pathogens “

… reads the headline from 2017 at the website nature.com

From WUHAN, CHINA. “Maximum-security biolab is part of plan to build network of BSL-4 facilities across China.”

A coincidence is it that 3 years later we have an outbreak of the coronavirus? EWR

The article:

“A laboratory in Wuhan is on the cusp of being cleared to work with the world’s most dangerous pathogens. The move is part of a plan to build between five and seven biosafety level-4 (BSL-4) labs across the Chinese mainland by 2025, and has generated much excitement, as well as some concerns.

Some scientists outside China worry about pathogens escaping, and the addition of a biological dimension to geopolitical tensions between China and other nations. But Chinese microbiologists are celebrating their entrance to the elite cadre empowered to wrestle with the world’s greatest biological threats.

“It will offer more opportunities for Chinese researchers, and our contribution on the BSL‑4-level pathogens will benefit the world,” says George Gao, director of the Chinese Academy of Sciences Key Laboratory of Pathogenic Microbiology and Immunology in Beijing. There are already two BSL-4 labs in Taiwan, but the National Bio-safety Laboratory, Wuhan, would be the first on the Chinese mainland.

The lab was certified as meeting the standards and criteria of BSL-4 by the China National Accreditation Service for Conformity Assessment (CNAS) in January. The CNAS examined the lab’s infrastructure, equipment and management, says a CNAS representative, paving the way for the Ministry of Health to give its approval. A representative from the ministry says it will move slowly and cautiously; if the assessment goes smoothly, it could approve the laboratory by the end of June.

BSL-4 is the highest level of biocontainment: its criteria include filtering air and treating water and waste before they leave the laboratory, and stipulating that researchers change clothes and shower before and after using lab facilities. Such labs are often controversial. The first BSL-4 lab in Japan was built in 1981, but operated with lower-risk pathogens until 2015, when safety concerns were finally overcome.

The expansion of BSL-4-lab networks in the United States and Europe over the past 15 years — with more than a dozen now in operation or under construction in each region — also met with resistance, including questions about the need for so many facilities.

“Viruses don’t know borders.”

The Wuhan lab cost 300 million yuan (US$44 million), and to allay safety concerns it was built far above the flood plain and with the capacity to withstand a magnitude-7 earthquake, although the area has no history of strong earthquakes. It will focus on the control of emerging diseases, store purified viruses and act as a World Health Organization ‘reference laboratory’ linked to similar labs around the world. “It will be a key node in the global biosafety-lab network,” says lab director Yuan Zhiming.

The Chinese Academy of Sciences approved the construction of a BSL-4 laboratory in 2003, and the epidemic of SARS (severe acute respiratory syndrome) around the same time lent the project momentum. The lab was designed and constructed with French assistance as part of a 2004 cooperative agreement on the prevention and control of emerging infectious diseases. But the complexity of the project, China’s lack of experience, difficulty in maintaining funding and long government approval procedures meant that construction wasn’t finished until the end of 2014.

The lab’s first project will be to study the BSL-3 pathogen that causes Crimean–Congo haemorrhagic fever: a deadly tick-borne virus that affects livestock across the world, including in northwest China, and that can jump to people.

Future plans include studying the pathogen that causes SARS, which also doesn’t require a BSL-4 lab, before moving on to Ebola and the West African Lassa virus, which do. Some one million Chinese people work in Africa; the country needs to be ready for any eventuality, says Yuan. “Viruses don’t know borders.”

Gao travelled to Sierra Leone during the recent Ebola outbreak, allowing his team to report the speed with which the virus mutated into new strains1. The Wuhan lab will give his group a chance to study how such viruses cause disease, and to develop treatments based on antibodies and small molecules, he says.

Muyi Xiao for Nature

The central monitor room at China’s National Bio-safety Laboratory.

The opportunities for international collaboration, meanwhile, will aid the genetic analysis and epidemiology of emergent diseases. “The world is facing more new emerging viruses, and we need more contribution from China,” says Gao. In particular, the emergence of zoonotic viruses — those that jump to humans from animals, such as SARS or Ebola — is a concern, says Bruno Lina, director of the VirPath virology lab in Lyon, France.

Many staff from the Wuhan lab have been training at a BSL-4 lab in Lyon, which some scientists find reassuring. And the facility has already carried out a test-run using a low-risk virus.

But worries surround the Chinese lab, too. The SARS virus has escaped from high-level containment facilities in Beijing multiple times, notes Richard Ebright, a molecular biologist at Rutgers University in Piscataway, New Jersey. Tim Trevan, founder of CHROME Biosafety and Biosecurity Consulting in Damascus, Maryland, says that an open culture is important to keeping BSL-4 labs safe, and he questions how easy this will be in China, where society emphasizes hierarchy. “Diversity of viewpoint, flat structures where everyone feels free to speak up and openness of information are important,” he says.

Yuan says that he has worked to address this issue with staff. “We tell them the most important thing is that they report what they have or haven’t done,” he says. And the lab’s inter­national collaborations will increase openness. “Transparency is the basis of the lab,” he adds.

The plan to expand into a network heightens such concerns. One BSL-4 lab in Harbin is already awaiting accreditation; the next two are expected to be in Beijing and Kunming, the latter focused on using monkey models to study disease.

Lina says that China’s size justifies this scale, and that the opportunity to combine BSL-4 research with an abundance of research monkeys — Chinese researchers face less red tape than those in the West when it comes to research on primates — could be powerful. “If you want to test vaccines or antivirals, you need a non-human primate model,” says Lina.

But Ebright is not convinced of the need for more than one BSL-4 lab in mainland China. He suspects that the expansion there is a reaction to the networks in the United States and Europe, which he says are also unwarranted. He adds that governments will assume that such excess capacity is for the potential development of bioweapons.

“These facilities are inherently dual use,” he says. The prospect of ramping up opportunities to inject monkeys with pathogens also worries, rather than excites, him: “They can run, they can scratch, they can bite.”

Trevan says China’s investment in a BSL-4 lab may, above all, be a way to prove to the world that the nation is competitive. “It is a big status symbol in biology,” he says, “whether it’s a need or not.”

SOURCE: https://www.nature.com/news/inside-the-chinese-lab-poised-to-study-world-s-most-dangerous-pathogens-1.21487

Thanks to abovetopsecret.com for the link.

Photo Credit: nature.com

Unvaccinated Children Pose ZERO Risk to Anyone: Harvard Immunologist to Legislators

From vaccineimpact.com

Dr-Tetyana-Obukhanych.jpg
Dr. Tetyana Obukhanych

An Open Letter to Legislators Currently Considering Vaccine Legislation from Tetyana Obukhanych, PhD

Dear Legislator:

My name is Tetyana Obukhanych. I hold a PhD in Immunology. I am writing this letter in the hope that it will correct several common misperceptions about vaccines in order to help you formulate a fair and balanced understanding that is supported by accepted vaccine theory and new scientific findings.

Do unvaccinated children pose a higher threat to the public than the vaccinated?

It is often stated that those who choose not to vaccinate their children for reasons of conscience endanger the rest of the public, and this is the rationale behind most of the legislation to end vaccine exemptions currently being considered by federal and state legislators country-wide.

You should be aware that the nature of protection afforded by many modern vaccines – and that includes most of the vaccines recommended by the CDC for children – is not consistent with such a statement.

I have outlined below the recommended vaccines that cannot prevent transmission of disease either because they are not designed to prevent the transmission of infection (rather, they are intended to prevent disease symptoms), or because they are for non-communicable diseases.

People who have not received the vaccines mentioned below pose no higher threat to the general public than those who have, implying that discrimination against non-immunized children in a public school setting may not be warranted.

1. IPV (inactivated poliovirus vaccine) cannot prevent transmission of poliovirus. (see appendix for the scientific study, Item #1). Wild poliovirus has been non-existent in the USA for at least two decades. Even if wild poliovirus were to be re-imported by travel, vaccinating for polio with IPV cannot affect the safety of public spaces. Please note that wild poliovirus eradication is attributed to the use of a different vaccine, OPV or oral poliovirus vaccine. Despite being capable of preventing wild poliovirus transmission, use of OPV was phased out long ago in the USA and replaced with IPV due to safety concerns.

2. Tetanus is not a contagious disease, but rather acquired from deep-puncture wounds contaminated with C. tetani spores. Vaccinating for tetanus (via the DTaP combination vaccine) cannot alter the safety of public spaces; it is intended to render personal protection only.

3. While intended to prevent the disease-causing effects of the diphtheria toxin, the diphtheria toxoid vaccine (also contained in the DTaP vaccine) is not designed to prevent colonization and transmission of C. diphtheriae. Vaccinating for diphtheria cannot alter the safety of public spaces; it is likewise intended for personal protection only.

4. The acellular pertussis (aP) vaccine (the final element of the DTaP combined vaccine), now in use in the USA, replaced the whole cell pertussis vaccine in the late 1990s, which was followed by an unprecedented resurgence of whooping cough. An experiment with deliberate pertussis infection in primates revealed that the aP vaccine is not capable of preventing colonization and transmission of B. pertussis. The FDA has issued a warning regarding this crucial finding. [1]

Furthermore, the 2013 meeting of the Board of Scientific Counselors at the CDC revealed additional alarming data that pertussis variants (PRN-negative strains) currently circulating in the USA acquired a selective advantage to infect those who are up-to-date for their DTaP boosters, meaning that people who are up-to-date are more likely to be infected, and thus contagious, than people who are not vaccinated.

5. Among numerous types of H. influenzae, the Hib vaccine covers only type b. Despite its sole intention to reduce symptomatic and asymptomatic (disease-less) Hib carriage, the introduction of the Hib vaccine has inadvertently shifted strain dominance towards other types of H. influenzae (types a through f). These types have been causing invasive disease of high severity and increasing incidence in adults in the era of Hib vaccination of children (see appendix for the scientific study, Item #4). The general population is more vulnerable to the invasive disease now than it was prior to the start of the Hib vaccination campaign. Discriminating against children who are not vaccinated for Hib does not make any scientific sense in the era of non-type b H. influenzae disease.

6. Hepatitis B is a blood-borne virus. It does not spread in a community setting, especially among children who are unlikely to engage in high-risk behaviors, such as needle sharing or sex. Vaccinating children for hepatitis B cannot significantly alter the safety of public spaces. Further, school admission is not prohibited for children who are chronic hepatitis B carriers. To prohibit school admission for those who are simply unvaccinated – and do not even carry hepatitis B – would constitute unreasonable and illogical discrimination.

In summary, a person who is not vaccinated with IPV, DTaP, HepB, and Hib vaccines due to reasons of conscience poses no extra danger to the public than a person who is. No discrimination is warranted.

How often do serious vaccine adverse events happen?

It is often stated that vaccination rarely leads to serious adverse events.

Unfortunately, this statement is not supported by science.

A recent study done in Ontario, Canada, established that vaccination actually leads to an emergency room visit for 1 in 168 children following their 12-month vaccination appointment and for 1 in 730 children following their 18-month vaccination appointment (see appendix for a scientific study, Item #5).

When the risk of an adverse event requiring an ER visit after well-baby vaccinations is demonstrably so high, vaccination must remain a choice for parents, who may understandably be unwilling to assume this immediate risk in order to protect their children from diseases that are generally considered mild or that their children may never be exposed to.

Can discrimination against families who oppose vaccines for reasons of conscience prevent future disease outbreaks of communicable viral diseases, such as measles?

Measles research scientists have for a long time been aware of the “measles paradox.” I quote from the article by Poland & Jacobson (1994) “Failure to Reach the Goal of Measles Elimination: Apparent Paradox of Measles Infections in Immunized Persons.” Arch Intern Med 154:1815-1820:

“The apparent paradox is that as measles immunization rates rise to high levels in a population, measles becomes a disease of immunized persons.” [2]

Further research determined that behind the “measles paradox” is a fraction of the population called LOW VACCINE RESPONDERS. Low-responders are those who respond poorly to the first dose of the measles vaccine. These individuals then mount a weak immune response to subsequent RE-vaccination and quickly return to the pool of “susceptibles’’ within 2-5 years, despite being fully vaccinated. [3]

Re-vaccination cannot correct low-responsiveness: it appears to be an immuno-genetic trait. [4] The proportion of low-responders among children was estimated to be 4.7% in the USA. [5]

Studies of measles outbreaks in Quebec, Canada, and China attest that outbreaks of measles still happen, even when vaccination compliance is in the highest bracket (95-97% or even 99%, see appendix for scientific studies, Items #6&7). This is because even in high vaccine responders, vaccine-induced antibodies wane over time. Vaccine immunity does not equal life-long immunity acquired after natural exposure.

It has been documented that vaccinated persons who develop breakthrough measles are contagious. In fact, two major measles outbreaks in 2011 (in Quebec, Canada, and in New York, NY) were re-imported by previously vaccinated individuals. [6] [7]

Taken together, these data make it apparent that elimination of vaccine exemptions, currently only utilized by a small percentage of families anyway, will neither solve the problem of disease resurgence nor prevent re-importation and outbreaks of previously eliminated diseases.

Is discrimination against conscientious vaccine objectors the only practical solution?

The majority of measles cases in recent US outbreaks (including the recent Disneyland outbreak) are adults and very young babies, whereas in the pre-vaccination era, measles occurred mainly between the ages 1 and 15.

Natural exposure to measles was followed by lifelong immunity from re-infection, whereas vaccine immunity wanes over time, leaving adults unprotected by their childhood shots. Measles is more dangerous for infants and for adults than for school-aged children.

Despite high chances of exposure in the pre-vaccination era, measles practically never happened in babies much younger than one year of age due to the robust maternal immunity transfer mechanism.

The vulnerability of very young babies to measles today is the direct outcome of the prolonged mass vaccination campaign of the past, during which their mothers, themselves vaccinated in their childhood, were not able to experience measles naturally at a safe school age and establish the lifelong immunity that would also be transferred to their babies and protect them from measles for the first year of life.

Luckily, a therapeutic backup exists to mimic now-eroded maternal immunity. Infants as well as other vulnerable or immunocompromised individuals, are eligible to receive immunoglobulin, a potentially life-saving measure that supplies antibodies directed against the virus to prevent or ameliorate disease upon exposure (see appendix, Item #8).

In summary:

1) due to the properties of modern vaccines, non-vaccinated individuals pose no greater risk of transmission of polio, diphtheria, pertussis, and numerous non-type b H. influenzae strains than vaccinated individuals do, non-vaccinated individuals pose virtually no danger of transmission of hepatitis B in a school setting, and tetanus is not transmissible at all;

2) there is a significantly elevated risk of emergency room visits after childhood vaccination appointments attesting that vaccination is not risk-free;

3) outbreaks of measles cannot be entirely prevented even if we had nearly perfect vaccination compliance; and

4) an effective method of preventing measles and other viral diseases in vaccine-ineligible infants and the immunocompromised, immunoglobulin, is available for those who may be exposed to these diseases.

Taken together, these four facts make it clear that discrimination in a public school setting against children who are not vaccinated for reasons of conscience is completely unwarranted as the vaccine status of conscientious objectors poses no undue risk to the public.

Sincerely Yours,

~ Tetyana Obukhanych, PhD

Tetyana Obukhanych earned her Ph.D. in Immunology at the Rockefeller University, New York, NY with her research dissertation focused on immunologic memory. She was subsequently involved in laboratory research as a postdoctoral research fellow at Harvard Medical School and Stanford University School of Medicine, before fully devoting herself to natural parenting.

(Original Source: legislature.vermont.gov – Testimony Senate Health & Welfare Committee Wednesday April 22, 2015 H.98 – public records)

Editor’s Note: This article has been slightly edited to reflect the language from the letter submitted to the Vermont General Assembly on April 22, 2015. As part of the Vermont Senate Health & Welfare Committee, it is a matter of public record and accessible here.)

UPDATE: The above links on the Vermont government website no longer work. Here is a copy.

 

For appendix also go to the SOURCE:

http://vaccineimpact.com/2017/harvard-immunologist-to-legislators-unvaccinated-children-pose-zero-risk-to-anyone/?fbclid=IwAR0wC_5o69DMo-Uwqhh0cFNkGKnNCPOdafNCrVhR9U66xKq2yLzLB9u0NJo

‘Biocidal Aotearoa’ – Hear an interview with NZ MD Fiona McQueen on 1080 (On the Brink Radio)

An excellent and informative interview. Fiona McQueen (MBChB, MD, FRACP) wrote The Quiet Forest, The Case Against Aerial 1080 in 2017. She graduated from the University of Otago in Medicine in 1980 and has worked as a consultant rheumatologist within the NZ public health system for the last 26 years. She completed an MD in Immunology in 1996 and was made Professor of Rheumatology in 2009. She has had a distinguished international academic career and has been active in research and teaching. She has had a life-long passion for tramping and experiencing the NZ bush, especially the alpine regions of the South Island. This has led to a deep interest in conservation. (Information cited from her book).

To listen click on the orange button below.

CDC Blocks Testimony by Vaccine Whistleblower in Medical Malpractice Case

hammer-719066_1280

Thomas Frieden, the director of the Center for Disease Control (CDC), has blocked CDC whistleblower, Dr. William Thompson, from testifying on scientific fraud and destruction of evidence by senior CDC officials in critical vaccine safety studies regarding the causative relationship between childhood vaccines and autism.

Attorneys Bryan Smith and Robert F. Kennedy, Jr., of Morgan & Morgan, have been seeking to have Dr. Thompson testify in a medical malpractice case to explain how the CDC committed scientific fraud in a series of studies, which found no link between vaccines and autism.

In denying the request, Dr. Frieden said, “Dr. William Thompson’s deposition testimony would not substantially promote the objectives of CDC or HHS [Health and Human Services].”

Dr. Thompson, a 19-year veteran at the CDC and former senior vaccine safety scientist at the agency’s Immunology Safety Office, is the co-author of four key studies that the CDC widely touts to exonerate the MMR vaccine and vaccines containing the mercury-based preservative thimerosal, from being linked to autism. Thompson is currently employed at the CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention.

syringe-417786_1280

In August 2014, Dr. Thompson revealed that the data underlying CDC’s principle vaccine safety studies demonstrated a causal link between vaccines and autism or autism symptoms, despite CDC’s claims to the contrary. According to Thompson, based upon interpretation of the data, “There is biologic plausibility right now to say that thimerosal causes autism-like features.” Dr. Thompson invoked federal whistleblower protection in August 2014.

READ MORE

http://www.ecowatch.com/cdc-vaccines-autism-2051536402.html?xrs=RebelMouse_fb